Uterine Atony
18
1
1
11
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
5.6%
1 terminated out of 18 trials
91.7%
+5.2% vs benchmark
56%
10 trials in Phase 3/4
55%
6 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (18)
Exploration and Determination of Genomic Markers Predictive of Uterine Atony
Cooling the Uterus in C-section After Dysfunctional Labor
Prophylactic Intravenous Calcium Gluconate to Decrease Blood Loss at Time of Cesarean Delivery in Pregnant Patients at High Risk for Uterine Atony
Second-Line Uterotonics in Postpartum Hemorrhage: A Randomized Clinical Trial
Calcium Chloride for Prevention of Blood Loss During Intrapartum Cesarean Delivery
Placental Removal Method And Uterine Massage On Preventing Postpartum Hemorrhage
Calcium Chloride for Prevention of Uterine Atony During Cesarean
Novel Approach of Hayman Uterine Compression Sutures for Management of Severe Atonic Postpartum Hemorrhage: Three Vertical Sutures
Intravenous Versus Intramuscular Administration of Methylergonovine for Uterine Contraction in Cesarean Sections
Uterine Cooling During Cesarean Delivery to Reduce Blood Loss and Incidence of Postpartum Hemorrhage
An Evidence Based Protocol for Oxytocin Administration in Vaginal Delivery
Oxytocin And Uterotonic Agent Use For Cesarean Delivery
Role of Tranexamic Acid Versus Uterine Cooling at Caesarean Section
Oxytocin Regimen to Prevent Atony and Postpartum Hemorrhage During Vaginal Delivery: 3-arm RCT
Comparison of Two Doses of Carbetocin for Prevention of Uterine Atony, During Elective Cesarean Section
ED90 Determination of Carbetocin for the Prevention of Uterine Atony in Women Undergoing an Elective Cesarean Delivery
Does Intramyometrial Oxytocin Improve Outcome in Elective Cesarean Delivery?
Up-Down Oxytocin Infusion